Nice (AFP) | 09/06/2025 - 20:57:26 | Gaza humanitarian blockade a 'scandal', shameful: Macron
Brasília (AFP) | 09/06/2025 - 20:25:04 | Bolsonaro trial co-accused testifies on plot to 'redo' election
Port of Ashdod (AFP) | 09/06/2025 - 20:05:33 | Gaza-bound aid boat intercepted by Israel reaches Ashdod port: AFP
Brasília (AFP) | 09/06/2025 - 19:26:56 | Bolsonaro, co-accused begin testifying in Brazil coup trial
London (AFP) | 09/06/2025 - 19:07:38 | 'The Day of The Jackal' author Frederick Forsyth dies aged 86: agent
United Nations (AFP) | 09/06/2025 - 18:55:52 | UN warns against 'further militarization' in LA unrest
Washington (AFP) | 09/06/2025 - 18:45:22 | Trump blames 'insurrectionists' for Los Angeles unrest
Washington (AFP) | 09/06/2025 - 18:29:04 | Trump calls troops deployment in Los Angeles 'great decision'
Mexico City (AFP) | 09/06/2025 - 16:37:11 | Mexico president condemns LA violence, urges respect for migrant 'dignity'
Toronto (AFP) | 09/06/2025 - 16:22:18 | Canada to hit 2% defense NATO spending target this year: Carney
By Phil Chetwynd, AFP Global News Director
The Israel-Hamas war is one of the most complex and divisive stories AFP has covered. It touches historical fault lines that are generating visceral emotions in our societies, and in our newsrooms.
RevBio, Inc., announced that it has received approval from the Medicines and Health Regulatory Agency (MHRA) to conduct a 15 patient pilot clinical trial to use TETRANITE® to reintegrate bone flaps, which are portions of the skull that are temporarily removed by neurosurgeons to perform brain surgery. This clinical trial is designed to demonstrate that TETRANITE can reintegrate these bone flaps with the surrounding bone to improve cosmesis, increase flap stability for patient comfort, and help ...
